The Efficacy of Travoprost/Timolol in Treating Glaucoma

Authors

• Yasmin Emam, University of Central FloridaFollow
• Sebastian Nieto, University of Central FloridaFollow
• Arnav Jain, University of Central FloridaFollow
• Chris Rodriguez, University of Central FloridaFollow
• Angelia Koppenhoefer, University of Central FloridaFollow

Streaming Media

Files

Course Code

HSC

Course Number

4930

Faculty/Instructor

Dr. Cheryl Cavaliere

Faculty/Instructor Email

Cheryl.Cavaliere@ucf.edu

About the Author

Hello! This presentation was prepared by Yasmin Emam, Angelia Koppenhoefer, Sebastian Nieto, Chris Rodriguez, and Arnav Jain during Dr. Cavaliere's HSC 4930 course in Spring 2026. We would like to express our appreciation to our professor for guidance, encouragement, and support provided throughout this project. We truly value the time and effort she invested into our learning and growth.

Abstract, Summary, or Creative Statement

This project focuses on evaluating the effectiveness of DuoTrav, a fixed-combination ophthalmic medication containing Travoprost 0.004% and Timolol 0.5%, in the treatment of open-angle glaucoma and ocular hypertension. The purpose of the researcher's study was to examine how this combination therapy compares to a beta-blocker monotherapy in reducing intraocular pressure (IOP), which is a major risk factor for optic nerve damage and vision loss in glaucoma patients.

Key activities included reviewing the cause of glaucoma, analyzing the design and results of a completed and randomized clinical trial, and applying the findings to clinical practice.

One of the most important things we learned was the significant clinical impact of lowering IOP, especially how even small reductions can greatly decrease the risk of glaucoma progression. We also learned the importance of translating research findings into patient care by considering treatment effectiveness, appropriate dosage, monitoring protocols, side effects, and patient adherence when applying evidence to clinical implementation.

Keywords

Glaucoma; Timolol; Ocular Disease; Travoprost; DuoTrav; Ocular Hypertension; IOP; Intraocular pressure; Tonometry; Clinical Trial; Open-angle Glaucoma; Optic Nerve Damage; Combination Therapy; Beta-blocker Monotherapy; Vision loss

Recommended Citation

Emam, Yasmin; Nieto, Sebastian; Jain, Arnav; Rodriguez, Chris; and Koppenhoefer, Angelia, "The Efficacy of Travoprost/Timolol in Treating Glaucoma" (2026). High Impact Practices Student Showcase Spring 2026. 10.
https://stars.library.ucf.edu/hip-2026spring/10